Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D). Towards an Artificial Pancreas [(SBIR) (R43/R44)]

Archived

National Institutes of Health

Description

Purpose. This FOA solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress toward an integrated long term glucose regulated insulin delivery system (artificial pancreas). Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications. Funds Available and Anticipated Number of Awards. The estimated amount of funds available for support of 5-10 projects awarded as a result of this announcement is $ 3.2M for fiscal year 2011. Future year amounts will depend on annual appropriations.

Who can apply

  • Small businesses

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV

Key dates & funding
  • PostedMay 19, 2010
  • ClosesNov 29, 2010
  • Program funding$3,200,000
  • CFDA93.847, 93.865

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro